All Stories

  1. Synthesis, Antimicrobial Evaluation and In silico Studies of Novel 2,4- disubstituted-1,3-thiazole Derivatives
  2. The Upshot of PI3K Inhibitors as Anticancer Arsenal: A Short Review
  3. Recent Advances in Cancer Drug Development: Targeting Induced Myeloid Cell Leukemia-1 (Mcl-1) Differentiation Protein
  4. Biological Activities and In Silico Physico-Chemical Properties of 1,2,3- Triazoles Derived from Natural Bioactive Alcohols
  5. Experimental and molecular docking investigation on DNA interaction ofN-substituted phthalimides: antibacterial, antioxidant and hemolytic activities
  6. Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy
  7. ChemInform Abstract: A Structure Guided Drug-Discovery Approach Towards Identification of Plasmodium Inhibitors
  8. A structure guided drug-discovery approach towards identification of Plasmodium inhibitors
  9. Effect of novel triazole–amino acid hybrids on growth and virulence of Candida species: in vitro and in vivo studies
  10. Evaluation of DNA Binding, Radicals Scavenging and Antimicrobial Studies of Newly Synthesized N-Substituted Naphthalimides: Spectroscopic and Molecular Docking Investigations
  11. Monocyclic β -lactam and unexpected oxazinone formation: synthesis, crystal structure, docking studies and antibacterial evaluation
  12. Synthesis, QSAR and anticandidal evaluation of 1,2,3-triazoles derived from naturally bioactive scaffolds
  13. Diketo acids and their amino acid/dipeptidic analogues as promising scaffolds for the development of bacterial methionine aminopeptidase inhibitors
  14. Polysulfated Trehalose as a Novel Anticoagulant Agent with Dual Mode of Action
  15. Elucidating the specificity of non-heparin-based conformational activators of antithrombin for factor Xa inhibition
  16. Synthesis of N-2-aryl-substituted-1,2,3-triazole Derivatives as Novel Inhibitors of Entamoeba histolytica
  17. Limitations of conventional anticoagulant therapy and the promises of non-heparin based conformational activators of antithrombin
  18. ChemInform Abstract: Synthesis, Spectral Studies and Antiamoebic Activity of New 1-N-Substituted Thiocarbamoyl-3-phenyl-2-pyrazolines.
  19. Synthesis, spectral studies and antiamoebic activity of new 1-N-substituted thiocarbamoyl-3-phenyl-2-pyrazolines
  20. Synthesis and antiamoebic activity of metronidazole thiosemicarbazone analogues
  21. Novel Pd(II) complexes of 1-N-substituted 3-phenyl-2-pyrazoline derivatives and evaluation of antiamoebic activity
  22. Synthesis, characterization and antiamoebic activity of new indole-3-carboxaldehyde thiosemicarbazones and their Pd(II) complexes
  23. Syntheses, characterization and in vitro antiamoebic activity of new Pd(II) complexes with 1-N-substituted thiocarbamoyl-3,5-diphenyl-2-pyrazoline derivatives
  24. Synthesis, Characterization and Antiamoebic Activity of 1-(Thiazolo[4,5-b]quinoxaline-2-yl)-3-phenyl-2-pyrazoline Derivatives.
  25. Synthesis, characterization and antiamoebic activity of 1-(thiazolo[4,5-b]quinoxaline-2-yl)-3-phenyl-2-pyrazoline derivatives
  26. Dioxovanadium(V) and μ-oxo bis[oxovanadium(V)] complexes containing thiosemicarbazone based ONS donor set and their antiamoebic activity
  27. 1-N-Substituted Thiocarbamoyl-3-phenyl-2-pyrazolines: Synthesis and in vitro Antiamoebic Activities.
  28. Synthesis, characterisation, reactivity and in vitro antiamoebic activity of hydrazone based oxovanadium(iv), oxovanadium(v) and µ-bis(oxo)bis{oxovanadium(v)} complexes
  29. Synthesis and Anti-Amoebic Activity of Gold(I), Ruthenium(II), and Copper(II) Complexes of Metronidazole
  30. Synthesis and antiamoebic activity of new oxime ether derivatives containing 2-acetylpyridine/2-acetylfuran
  31. Synthesis and antiamoebic activities of 1-N-substituted cyclised pyrazoline analogues of thiosemicarbazones